Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 9, 35-41, January 1, 1949]
© 1949 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, M. H.
Right arrow Articles by Gardner, W. U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, M. H.
Right arrow Articles by Gardner, W. U.

Further Studies on the Pathogenesis of Ovarian Tumors in Mice*

Min Hsin Li, Ph.D.{dagger} and W. U. Gardner, Ph.D.

(From the Department of Anatomy, Yale University School of Medicine, New Haven, Connecticut)

1. Granulosa-cell tumors, luteomas, and mixed tumors (granulosa and luteoma cells) developed in intrasplenic ovarian grafts in castrated male and female mice. There is apparently no strain limitation in the formation of these tumors in mice.
2. No ovarian tumors were observed in the intrasplenic grafts of ovaries in (a) unilaterally gonadectomized mice, (b) gonadectomized mice that received estradiol benzoate or testosterone propionate, or (c) gonadectomized mice with vascularized adhesion that permitted ovarian hormones to by-pass the hepatic portal circulation. The gonadal hormones are assumed to act indirectly by inhibiting the production and secretion of the pituitary gonadotrophic hormones.
3. Weekly treatment with 1 mg. of progesterone did not prevent tumor formation in intrasplenic ovarian grafts.
4. Daily injections of a gonadotrophin from the pregnant mare's serum (PMS) exerted luteinizing influence on the ovarian tumors.
5. The malignancy of the induced granulosacell tumors is shown by the ability to metastasize and the transplantability into new hosts.
6. These experimental results appear to substantiate further the assumption that prolonged stimulation by increased amounts of gonadotrophic hormones is responsible for the genesis of ovarian tumors.

* Presented at the annual meeting of the American Association for Cancer Research, Chicago, May 16, 1947. This research has been aided by grants from the Anna Fuller Fund and the Jane Coffin Childs Memorial Fund for Medical Research.

{dagger} Anna Fuller Fund Fellow in anatomy. Now at the National University of Peking, Peiping, China.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
C. C. Capen
Mechanisms of Hormone-Mediated Carcinogenesis of the Ovary
Toxicol Pathol, February 1, 2004; 32(2_suppl): 1 - 5.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
S. I. GRIBOFF
THE RATIONALE AND CLINICAL USE OF STEROID HORMONES IN CANCER
Arch Intern Med, May 1, 1952; 89(5): 812 - 852.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1949 by the American Association for Cancer Research.